Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $432B
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Quarter Return
+3.1%
1 Year Return
+19.15%
3 Year Return
+80.48%
5 Year Return
+182.76%
10 Year Return
+378.45%
AUM
$106B
AUM Growth
Cap. Flow
+$106B
Cap. Flow %
100%
Top 10 Hldgs %
8.59%
Holding
3,585
New
3,585
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Financials 19.18%
2 Industrials 12.66%
3 Energy 10.8%
4 Technology 9.12%
5 Consumer Discretionary 8.78%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RMTI icon
3576
Rockwell Medical
RMTI
$58.9M
$1K ﹤0.01% +300 New +$1K
AXU
3577
DELISTED
Alexco Resource Corp.
AXU
$1K ﹤0.01% +1,285 New +$1K
GPL
3578
DELISTED
Great Panther Mining Limited
GPL
$1K ﹤0.01% +1,300 New +$1K
ARRY
3579
DELISTED
Array Biopharma Inc
ARRY
$1K ﹤0.01% +300 New +$1K
CVO
3580
DELISTED
Cenevo, Inc.
CVO
$1K ﹤0.01% +400 New +$1K
VOCS
3581
DELISTED
VOCUS INC
VOCS
$1K ﹤0.01% +100 New +$1K
CADX
3582
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$1K ﹤0.01% +100 New +$1K
AUDC icon
3583
AudioCodes
AUDC
$273M
$0 ﹤0.01% +100 New
PSTV icon
3584
Plus Therapeutics
PSTV
$45.3M
$0 ﹤0.01% +100 New